Maryland Legislative Sessions: IPMD Past Supported Bills

2020/2021 Supported Bills

Click the button to send a message to your Maryland state legislator
HB 601  SIGNED BY THE GOVERNOR

​HB 601 – PBM: DEFINITION OF A PURCHASER AND ERISA – BY DELEGATE KIPKE

STATUS UPDATE: Signed by the Governor

Law Effective January 1, 2022

FOR the purpose of altering the definition of “purchaser” for the purposes of certain provisions of State insurance law governing pharmacy benefits managers to repeal the exclusion of certain persons that provide prescription drug coverage or benefits through plans subject to ERISA; repealing a certain definition, and generally relating to pharmacy benefits managers and plans subject to ERISA. 

Importance:

By amending the Insurance Article, this bill streamlines the definition of "pharmacy benefits manager" in relation to their purpose in the healthcare system and implements elements of the Rutledge v PCMA SCOTUS decision by allowing the state to regulate ERISA plan PBM practices. It also places restrictions and guidelines on pharmacy audits to prevent predatory tactics, and broadens the scope of care pharmacies may provide to their patients.

HB 602

​HB 602 – EMERGENCY BILL MMCD/PBM REIMBURSEMENT REUIREMENT - BY DELEGATE KIPKE

*   A  PBM must reimburse the pharmacy an amount that is at least equal to the National Average Drug Acquisition Cost (NADAC), plus the fee for service – professional dispensing fee determined by the Marylan Department of Health or the Maryland Medical Assistance Program in accordance with the most recent in-state cost of dispensing survey

HB 607

HB 607 – STATE HEALTH & WELFARE BENEFITS PROGRAM: REQUIREMENTS FOR SELECTION OF A PHARMACY BENEFITS MANAGER – BY DELEGATE KIPKE

AMENDMENT TO THE 2020 LEGISLATIVE SESSION REVERSE AUCTION BILL

Terms of a participant bidding agreement: 

  • all bidders must accept as a prerequisite for participation in the reverse auction shall include a requirement that a bidder, if selected as a PBM for the Maryland Prescription Drug Program, pay a fee-for-service professional dispensing fee to a pharmacy which is based on an in-state cost to dispense market survey

  • the department shall require that the fee-for-service professional dispensing fee required will be stated by the bidder in the bid submitted in the reverse auction

HB 603

​HB 603 – PHARMACY BENEFITS MANAGERS – EXPLANATION OF BENEFITS - BY DELEGATE KIPKE

*   On a quarterly basis a PBM shall provide an explanation of benefits statement, on a form approved by the commissioner, to each beneficiary for whom the PBM processed or paid a claim for prescription drugs during the immediately preceding 3-month period.

The EOB will contain the following:

  • a copayment or other cost-sharing amount paid by the beneficiary

  • the amount of the payment, reimbursement, or other disbursement made to the dispensing pharmacy by the PBM 

  • the amount billed by the PBM to the purchaser

  • other information that the commissioner requires by regulation to ensure that the EOB statement provides the beneficiary with accurate and clear information regarding the processing and reimbursement of claims by the PBM

HB 709 / SB 614

HB 709/SB 614 – PBM - DRUG REIMBURSEMENT - REPORTING REQUIREMENTS – By DELEGATE KREBS / SENATOR JUSTIN READY

This provision of the insurance article will apply to PBMs that contract with Managed Care Organizations (MCOs) in the same manner as they apply to PBMs that contract with carriers.

Beginning January 1, 2022, and every 3 months thereafter, each PBM shall file with the Commissioner a report of all drugs appearing on the National Drug Acquisition Cost (NADAC) List that were reimbursed by the PBM at an amount below the NADAC cost plus the fee-for-service professional dispensing fee determined by the MD Dept. of Health for the MD Medical Assistance Program in accordance with the most recent in-state cost-of-dispensing survey.

For each drug listed on the report the following must be included:

  • the month the drug was dispensed

  • the quantity of the drug that was dispensed

  • the amount the pharmacy was reimbursed per unit or dosage

  • whether the dispensing pharmacy was an affiliate of the PBM

  • whether the drug was reimbursed in accordance with a state or local government health plan

  • the NADAC cost on the day the drug was dispensed

This information will be made available to the public by the Commissioner. This subsection may not be construed to preempt or conflict with any federal law or regulation (ERISA)

HB 819 / SB 615

​HB 819/SB 615 – PBMs - PROHIBITED ACTIONS. BY DELEGATE KREBS / SENATOR JUSTIN READY​

The bill adds to actions that may not be taken by a Pharmacy Benefit Manager (PBM) against a pharmacy. Under the bill, a PBM may not:

  • diminish reimbursement to a pharmacy for a prescription based on patient outcomes; 

  • engage in the practice of “spread pricing”, which is where the PBM charges a prescription plan one price for a drug, and then pays the pharmacy a lesser amount, the PBM then pocketing the difference; 

  • deny any pharmacy the right to participate in a prescription plan, as long as the pharmacy agrees to meet the terms and conditions of the plan; 

  • set different fees for a copay, based on whether the pharmacy is affiliated with an independent or a chain pharmacy; 

  • require that a beneficiary of a plan use a mail-order pharmacy to fill a prescription.
     

2019/2020 Supported Bills

HB 756

​HB 756 – MARYLAND MEDICAL ASSISTANCE PROGRAM AND MANAGED CARE ORGANIZATIONS THAT USE PHARMACY BENEFITS MANAGERS – REIMBURSEMENT REQUIREMENTS BY DELEGATE KIPKE

*   A  PBM must reimburse the pharmacy an amount that is at least equal to the National Average Drug Acquisition Cost (NADAC), plus the fee for service – professional dispensing fee determined by the Maryland Medical Assistance program.

Target Effective date:  Emergency bill. Immediate.

Status: In Committee

HB 1307

Effective date:  1/1/2021

Status: ENACTED into law without Governor's signature

HB 1307 – PHARMACY BENEFITS MANAGERS – NETWORK ADEQUACY AND REIMBURSEMENT – BY DELEGATE KIPKE, ET.AL.

See full law text & description

HB 663

Effective Date:  10/1/2020

Status: ENACTED into law without Governor's signature

HB 0663 – Prescription Drug Monitoring Program - Out-of-State Pharmacists and Discipline for Noncompliance – By Chair, Health and Government Operations Committee (Departmental - MDH)

See full law text & description

HB 1100

Effective Date:  6/1/2021

Status: ENACTED into law without Governor's signature

HB 1100 – Prescription Drug Affordability Board - Meetings, Legal Advisor, and Technical Changes – BY DELEGATE PENDERGRASS

See full law text & description

SB 99

Effective Date:  1/1/2021

Status: ENACTED into law without Governor's signature

SB 0099 – Health Insurance Benefit Cards, Prescription Benefit Cards and Other Technology - Identification of Regulatory Agency – By Chair, Finance Committee (Departmental - MIA)

See full law text & description

SB 477/HB 1462

Effective Date:  10/1/2021

Status: ENACTED into law without Governor's signature

SB 0477/HB 1462 – Public Health - Emergency Use Auto-Injectable Epinephrine Proram - Revisions – BY SENATOR CAROZZA

See full law text & description

HB 885

​HB 885 – PHARMACY BENEFITS MANAGERS – DUTIES AND OBLIGATIONS BY DELEGATES SAMPLE-HUGHES & KIPKE

*   Establishes a fiduciary relationship between the PBM and the plan sponsor and beneficiary.  In essence, the duties and obligations of the PBM must be consistent with the best interest of the plan sponsor (purchaser) and beneficiaries (subscribers) and not just what is in the best interest of the PBM.

Target Effective date:  10/1/2020

Status: In Committee

 

HB 652/SB 931

Effective date:  Emergency bill. Immediate.

Status: ENACTED into law without Governor's signature

​HB 652/SB 931 – MARYLAND MEDICAL ASSISTANCE PROGRAM AND HEALTH INSURANCE – SPECIALTY DRUGS – DEFINITION BY DELEGATE KIPKE, ET.AL. AND CROSS-FILED BY SENATOR HAYES​

See full law text & description

HB 512

Effective date:  1/1/2022

Status: ENACTED into law without Governor's signature

​HB 0512 – Drugs and Devices - Electronic Prescriptions - Controlled Dangerous Substances – BY DELEGATE BARRON

See full law text & description

SB 669/HB 1095

Effective date:  6/1/2020

Status: ENACTED into law without Governor's signature

​SB 0669/HB 1095 – Public Health - Prescription Drug Affordability Board and Fund – By President (Prescription Drug Affordability Board and Fund)

See full law text & description

HB 749

Effective date:  10/1/2022

Status: ENACTED into law without Governor's signature

​HB 0749 – Health Occupations - Dental Hygienists - Authority to Prescribe and Administer Medication – BY DELEGATE KIPKE​

See full law text & description

HB 1273

Effective date:  10/1/2020

Status: ENACTED into law without Governor's signature

​HB 1273 – Health Insurance – Audits of Pharmacies or Pharmacists – Authorization to Withdraw and Resubmit Claims – BY DELEGATE JOHNSON

See full law text & description

HB 1462/SB 477

Effective date:  10/1/2020

Status: ENACTED into law without Governor's signature

​HB 1462/SB 0477 – Public Health - Emergency Use Auto-Injectable Epinephrine Proram - Revisions – BY DELEGATE METZGAR

See full law text & description

SB 166

Effective date:  1/1/2022

Status: ENACTED into law without Governor's signature

​SB 0166 – Drugs and Devices - Electronic Prescriptions - Controlled Dangerous Substances – BY SENATOR KELLEY

See full law text & description

HB 1095/SB 669

FAILED

Status: Vetoed by Governor

​HB 1095/SB 0669 – Public Health - Prescription Drug Affordability Board and Fund – By Speaker (Prescription Drug Affordability Board)

See full law text & description

SB 931/HB 652

Effective date:  Emergency bill. Immediate.

Status: ENACTED into law without Governor's signature

SB 0931/HB 0652 – Maryland Medical Assistance Program and Health Insurance - Specialty Drugs - BY SENATOR HAYES​

See full law text & description